Thus, therapeutic targeting of NLRP3, NLRC4, and NLRP4 inflammasome during Gram-positive bacteria-induced severe pneumonia responsible for ALI may prove beneficial to the host. The gene discussed is NLRP3; the disease is susceptibility to pneumonia measurement.